CCF Highlights

A look at how the synergy between artificial intelligence and clinical expertise is potentially shaping the outlook of cholangiocarcinoma care.

Uncover how clinical trials are transforming cholangiocarcinoma treatment, offering patients personalized therapies, expanded options, and new hope for the future.

Explore how cellular immunotherapy, from tumor-infiltrating lymphocytes to circulating tumor-reactive T cells, is expanding the treatment landscape for cholangiocarcinoma.

Antibody-drug conjugates show potential in cancer treatment and may signal new possibilities for biliary tract cancer patients in this significant exploration.

Hepatic arterial infusion pump chemotherapy is transforming treatment for intrahepatic cholangiocarcinoma by improving survival rates and enhancing quality of life.

Targeting protein arginine methyltransferases offers a promising new approach to combat cholangiocarcinoma by suppressing tumor growth and enhancing immune responses.

Discover how emergent research on CAR T-cell therapy is paving the way for new possibilities in cholangiocarcinoma treatment.

Cutting-edge research on therapeutic resistance and innovative combination strategies is adding new possibilities to the fight against cholangiocarcinoma.

Experts unveiled a roadmap for translating cutting-edge biomarkers into clinical practice, paving the way for improved early detection and personalized care in high-risk populations with cholangiocarcinoma (CCA).

Leading experts explored groundbreaking advancements in tumor microenvironments, biomarker validation, and innovative therapies, paving the way for transformative precision medicine in cholangiocarcinoma (CCA) care.